Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol

被引：0
|
作者：
Kirsten J. Langdon
Anthony E. Hitch
Alexandra B. Collins
Curt G. Beckwith
Sara Becker
Karen Tashima
Josiah D. Rich
机构：
[1] Rhode Island Hospital,Department of Psychiatry
[2] Alpert Medical School of Brown University,Department of Psychiatry and Human Behavior
[3] Brown-Lifespan Center for Digital Health,Department of Psychology
[4] University of Cincinnati,Department of Epidemiology
[5] Brown University School of Public Health,Center for Dissemination and Implementation Science
[6] Northwestern University,Department of Medicine, Division of Infectious Diseases
[7] Brown University and The Miriam and Rhode Island Hospitals,undefined
来源：
Addiction Science & Clinical Practice | / 18卷
关键词：
Opioid use disorder; HIV; Medications for opioid use disorder; Long-acting injectable medication; Antiretroviral therapy; Antiviral resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol
    Langdon, Kirsten J.
    Hitch, Anthony E.
    Collins, Alexandra B.
    Beckwith, Curt G.
    Becker, Sara
    Tashima, Karen
    Rich, Josiah D.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [2] Developing Long-Acting Injectable Formulations for Opioid Use Disorder Treatment
    Ingabire, Diane
    Xu, Qingguo
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (03):
  • [3] Predictors of availability of long-acting medication for opioid use disorder
    Shover, Chelsea L.
    Humphreys, Keith
    DRUG AND ALCOHOL DEPENDENCE, 2019, 204
  • [4] Medications for Treatment of Opioid Use Disorder among Persons Living with HIV
    Fanucchi, Laura
    Springer, Sandra A.
    Korthuis, P. Todd
    CURRENT HIV/AIDS REPORTS, 2019, 16 (01) : 1 - 6
  • [5] Medications for Treatment of Opioid Use Disorder among Persons Living with HIV
    Laura Fanucchi
    Sandra A. Springer
    P. Todd Korthuis
    Current HIV/AIDS Reports, 2019, 16 : 1 - 6
  • [6] Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations
    Lofwall, Michelle R.
    Fanucchi, Laura C.
    PREVENTIVE MEDICINE, 2021, 152
  • [7] Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges
    Christopoulos, Katerina A.
    Hickey, Matthew D.
    Rana, Aadia
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 11 - 18
  • [8] Patients' decisions to initiate long-acting injectable buprenorphine for opioid use disorder: Qualitative study
    Neale, Joanne
    Parkin, Stephen
    Strang, John
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S127 - S128
  • [9] Treatment adherence and virological suppression in an outpatient cohort of people living with HIV (PLWH) on long-acting injectable HIV therapy
    Dannenberg, Catharina
    Almahfoud, Maher
    Weimann, Lukas
    Matthews, Hanna
    Degen, Olaf
    zur Wiesch, Julian Schulze
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 119 - 120
  • [10] A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the US
    Simoni, Jane M.
    Tapia, Kenneth
    Lee, Sung-Jae
    Graham, Susan M.
    Beima-Sofie, Kristin
    Mohamed, Zahra H.
    Christodoulou, Joan
    Ho, Rodney
    Collier, Ann C.
    AIDS AND BEHAVIOR, 2020, 24 (04) : 1226 - 1236
12345